Medication info
Danofen Semi Tablet

Danofen Semi Tablet

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›18.75mg / 1 tabletAcetaminophen›162.5mg / 1 tablet
Manufacturer / importer
(Yu) Hanpoong Pharmaceutical Co., Ltd.
Appearance
Pale yellow oblong film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201903792 · Approved 2019.06.10 · Insurance code 658106370

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, perform regular monitoring to determine whether treatment with this drug should be continued. Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, perform regular monitoring to determine whether treatment with this drug should be continued.

Ingredients

Manufacturer
(Yu) Hanpoong Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • moderate to severe chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Adults: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, perform regular monitoring to determine whether treatment with this drug should be continued. Older adults Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was administered orally to older adults aged 75 years or older, administer this drug at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this drug after dialysis to maintain analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this drug to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's level of pain and response to treatment. An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this drug for longer than necessary. If long-term treatment is required because of the nature and severity of the disease, perform regular monitoring to determine whether treatment with this drug should be continued.

Precautions

This drug may place a burden on the liver, so individuals who regularly consume more than three glasses of alcohol a day must consult a doctor or pharmacist before taking this medication. If any abnormal reactions such as rash or itching occur during the use of this drug, discontinue use immediately and consult a healthcare professional. One of the active ingredients in this drug, tramadol, can increase the risk of seizures; therefore, patients with a history of seizures or those at high risk of seizures should use it with caution. Taking tramadol in conjunction with certain antidepressants, narcotics, or sedatives may increase the risk of seizures, so consult a healthcare professional before co-administering. Acute and severe bronchial asthma patients may experience severe respiratory suppression when using this drug, so it must be administered in a monitored environment. Taking this drug with alcohol or benzodiazepine medications can cause severe drowsiness, respiratory suppression, and coma, so co-administration should be avoided. Patients with head injuries or elevated intracranial pressure should be cautious as the drug may worsen symptoms due to respiratory suppression and increased brain pressure. This drug can cause addiction and dependence, so long-term use should be monitored closely for signs of dependence. Patients with poor liver function may suffer liver damage from the acetaminophen contained in this drug, so they should consult a doctor before use. Certain genotypes (CYP2D6 ultrarapid metabolizers) can metabolize the components of this drug quickly, increasing the risk of severe side effects like respiratory suppression; caution is advised. This drug should not be administered to children under 12 years of age or to adolescents under 18 years who have undergone tonsil and adenoid surgery. Patients with sleep apnea or at risk of hypoxia should continuously monitor for exacerbation of symptoms after taking this drug and adjust the dosage if necessary. This drug can cause hyponatremia, so especially in the elderly or patients with risk factors, sodium levels should be monitored periodically. This drug may interact with certain medications, so be sure to inform healthcare professionals if taking other medicines, and caution is advised during co-administration. Drowsiness or dizziness may occur when driving or operating machinery, so caution is required. In case of overdose, serious side effects such as respiratory suppression, seizures, and liver damage may occur, so prescribed dosages must be observed, and immediate emergency measures should be taken in case of overdose. Keep out of reach of children to prevent accidental ingestion.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, liver failure, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, hypersomnia, decreased sensation, tremors, paresthesia, attention deficit, syncope, memory impairment, psychomotor agitation, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, perspiration, urinary disorders, erectile dysfunction, weakness, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylactic reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal thoughts, hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, high-anion-gap metabolic acidosis, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, vertigo, confusion, worsening migraine, involuntary muscle contractions, exercise-induced dyspnea, cough, bronchitis, urine retention, frequent urination, abnormal renal function tests, oliguria, increased rash, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, thrombocytopenia, arrhythmia, worsening hypertension, aortic stenosis, bleeding, elevated cholesterol, tinnitus, buttock pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver dysfunction, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, confusion, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, withdrawal symptoms, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, hypertrichosis, agitation, nervousness, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system responses, QT prolongation, respiratory depression, hypersomnia, coma, cardiac arrest, death

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, and it is recommended to keep it at room temperature between 1 to 30 degrees Celsius. This way, the medication's effectiveness can be maintained and degradation can be prevented.

Appearance and packaging

Appearance

Pale yellow oblong film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.